GlassScriptPhysician profile
Andrea E Zanders
NPI 1013745900
$572.13
in general payments reported to CMS, 2019-2025
14 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $132 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $130.57 | 2024-2025 | Abilify Maintena, Rexulti |
| Otsuka America Pharmaceutical, INC. | $103.72 | 2024-2025 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $77.44 | 2025 | Aristada, Lybalvi, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.54 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $33.07 | 2025 | Uzedy |
| Vanda Pharmaceuticals INC. | $28.74 | 2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $28.26 | 2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $21.11 | 2025 | Trintellix |
| Luye Pharma (USA) LTD. | $20.47 | 2025 | Erzofri Extended-Release |
| Neurocrine Biosciences, INC. | $20.12 | 2024 | Ingrezza |
| Noven Therapeutics, LLC | $18.44 | 2025 | Secuado |
| Janssen Pharmaceuticals, INC | $18.01 | 2025 | Spravato |
| Corium, LLC | $14.18 | 2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $13.46 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Zanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.